XNW28012

· Evopoint Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XNW28012, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments [Phase 1, Phase 2]